UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009168
Receipt number R000010759
Scientific Title The functional analysis of immune receptors on human primary mast cell
Date of disclosure of the study information 2012/10/25
Last modified on 2016/04/22 13:35:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The functional analysis of immune receptors on human primary mast cell

Acronym

The functional analysis of immune receptors on human primary mast cell

Scientific Title

The functional analysis of immune receptors on human primary mast cell

Scientific Title:Acronym

The functional analysis of immune receptors on human primary mast cell

Region

Japan


Condition

Condition

diffuse lung diseases

Classification by specialty

Pneumology Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To clarify the expression and function of immune receptors on human primary mast cell in airway.

Basic objectives2

Others

Basic objectives -Others

To establish the methodology of cellular biological analysis for human primary mast cell

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

expression and function of immune receptors, and identification of novel immune receptors on human primary mast cell.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Broncho alveolar lavage fluid samples obtained from the patient with diffuse lung diseases who had applicablity of broncho alveolar lavage test.

Key exclusion criteria

none

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Shibuya

Organization

Division of Biomedical sciences, Faculty of Medicine

Division name

Department of immunology

Zip code


Address

1-1-1, Ten-nodai, Tsukuba, Ibaraki, JAPAN

TEL

029-853-3281

Email

ashibuya@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kei Nagai

Organization

University of Tsukuba

Division name

Immunology

Zip code


Address

1-1-1, Ten-nodai, Tsukuba, Ibaraki, JAPAN

TEL

029-853-3281

Homepage URL


Email

s1030509@u.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Create revolutionary technological seeds for science and technology innovation (CREST), Japan science and technology agency (JST)

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波大学附属病院(茨城県)


Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 25 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076160

Number of participants that the trial has enrolled


Results

We determined expression and function of immunoreceptors (mainly, Allergin-1) in this study.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 10 Month 20 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 25 Day

Last follow-up date

2014 Year 12 Month 01 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete

2015 Year 03 Month 31 Day

Date analysis concluded

2015 Year 06 Month 01 Day


Other

Other related information

To evaluate the expression and function of immune receptors on human primary mast cell in airway with diffuse lung diseases in vitro. To identify a novel immune receptor from gene obtained from isolated human primary mast cell in airway.


Management information

Registered date

2012 Year 10 Month 23 Day

Last modified on

2016 Year 04 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010759


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name